Literature DB >> 16871549

Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.

Kimme L Hyrich1, Deborah P M Symmons, Kath D Watson, Alan J Silman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871549     DOI: 10.1002/art.22028

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  20 in total

1.  [Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment].

Authors:  J-A Rump; H Schönborn
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 2.  Treating rheumatic diseases in pregnancy: dos and don'ts.

Authors:  M D Lockshin
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 3.  TNFalpha blockade in human diseases: an overview of efficacy and safety.

Authors:  Jan Lin; David Ziring; Sheetal Desai; Sungjin Kim; Maida Wong; Yael Korin; Jonathan Braun; Elaine Reed; David Gjertson; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-04       Impact factor: 3.969

4.  Therapy: are TNF inhibitors safe in pregnancy?

Authors:  Monika Østensen
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

Review 5.  Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

Authors:  Ashima Makol; Kerry Wright; Shreyasee Amin
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

6.  Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries.

Authors:  Aditi I Dagli; Philip J Lee; Catherine E Correia; Christina Rodriguez; Kaustav Bhattacharya; Linda Steinkrauss; Charles A Stanley; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2010-04-13       Impact factor: 4.982

Review 7.  Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors:  Megan L Krause; Shreyasee Amin; Ashima Makol
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

8.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

9.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

Review 10.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.